Ally Financial’s Eli Lilly LLY Stock Holding History

Ally Financial’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.4M	Sell	2,000 -6,500	-76%	-$6.64M	0.31%	79
2026 Q1	$7.82M	Buy	8,500 +4,500	+113%	+$4.56M	0.97%	22
2025 Q4	$4.3M	Sell	4,000 -15,000	-79%	-$14.3M	0.52%	42
2025 Q3	$14.5M	Buy	19,000 +4,000	+27%	+$2.98M	1.79%	8
2025 Q2	$11.7M	Buy	15,000 +2,000	+15%	+$1.55M	1.32%	12
2025 Q1	$10.7M	Buy	13,000 +4,000	+44%	+$3.33M	1.2%	17
2024 Q4	$6.95M	Buy	9,000 +7,000	+350%	+$5.8M	0.85%	24
2024 Q3	$1.77M	Buy	+2,000	New	+$1.8M	0.21%	77
2018 Q3	–	Sell	-15,000	Closed	-$1.28M	–	119
2018 Q2	$1.28M	Hold	15,000	–	–	0.25%	93
2018 Q1	$1.16M	Buy	+15,000	New	+$1.21M	0.17%	107
2017 Q1	–	Sell	-35,000	Closed	-$2.57M	–	114
2016 Q4	$2.57M	Buy	35,000 +15,000	+75%	+$1.12M	0.43%	62
2016 Q3	$1.6M	Hold	20,000	–	–	0.28%	81
2016 Q2	$1.57M	Hold	20,000	–	–	0.26%	97
2016 Q1	$1.44M	Buy	+20,000	New	+$1.51M	0.2%	114
2014 Q2	–	Sell	-100,000	Closed	-$5.89M	–	139
2014 Q1	$5.89M	Hold	100,000	–	–	0.63%	53
2013 Q4	$5.1M	Hold	100,000	–	–	0.54%	74
2013 Q3	$5.03M	Hold	100,000	–	–	0.55%	68
2013 Q2	$4.91M	Buy	+100,000	New	+$5.44M	0.48%	84

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ally Financial's LLY Position: Q2 2026 in Review

Ally Financial reduced its Eli Lilly (LLY) stake by 76% in Q2 2026, selling an estimated $6.64M and leaving 2,000 shares worth $2.4M. The position accounts for 0.31% of the portfolio, ranked #79.

Ally Financial first reported a position in LLY in Q2 2013 and has held it in 18 quarters since. The position peaked at $14.5M in Q3 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Ally Financial held 2,000 shares of Eli Lilly worth $2.4M as of Q2 2026.
Ally Financial sold 6,500 Eli Lilly shares in Q2 2026, an estimated $6.64M.
Eli Lilly made up 0.31% of Ally Financial's portfolio in Q2 2026, its #79 holding.
Ally Financial first reported a position in Eli Lilly in Q2 2013 and has held it in 18 quarters since.
Ally Financial's Eli Lilly position peaked at $14.5M in Q3 2025.
4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ally Financial's 13F filing for Q2 2026, filed 13 Aug 2026.